Epigenetics: histone methyltransferase mutations promote leukaemia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

1. MicroRNA-107 promotes apoptosis of acute myelocytic leukemia cells by targeting RAD51.Archives of medical science : AMS · 2021
   Article
2. A Network-guided Association Mapping Approach from DNA Methylation to Disease.Scientific reports · 2019
   Article
3. Estimating the effects of transcription factors binding and histone modifications on gene expression levels in human cells.Oncotarget · 2017
   Article
4. Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML.International journal of genomics · 2017
   Article

Corrections and comments

• Comment on
  Identification of functional cooperative mutations of SETD2 in human acute leukemia.2014

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as